Literature DB >> 17942692

Inhibition of 5-HT neuron activity and induction of depressive-like behavior by high-frequency stimulation of the subthalamic nucleus.

Yasin Temel1, Laura J Boothman, Arjan Blokland, Peter J Magill, Harry W M Steinbusch, Veerle Visser-Vandewalle, Trevor Sharp.   

Abstract

Bilateral, high-frequency stimulation (HFS) of the subthalamic nucleus (STN) is the surgical therapy of choice for movement disability in advanced Parkinson's disease (PD), but this procedure evokes debilitating psychiatric effects, including depressed mood, of unknown neural origin. Here, we report the unexpected finding that HFS of the STN inhibits midbrain 5-hydroxytryptamine (5-HT) neurons to evoke depression-related behavioral changes. We found that bilateral HFS of the STN consistently inhibited (40-50%) the firing rate of 5-HT neurons in the dorsal raphe nucleus of the rat, but not neighboring non-5-HT neurons. This effect was apparent at clinically relevant stimulation parameters (> or =100 Hz, > or =30 microA), was not elicited by HFS of either neighboring or remote structures to the STN, and was still present in rat models of PD. We also found that bilateral HFS of the STN evoked clear-cut, depressive-like behavior in a widely used experimental paradigm of depression (forced swim test), and this effect was also observed in a PD model. Importantly, the depressive-like behavior elicited by HFS of the STN was reversed by a selective 5-HT-enhancing antidepressant, thereby linking the behavioral change to decreased 5-HT neuronal activity. Overall, these findings link reduced 5-HT function to the psychiatric effects of HFS of the STN observed in PD patients and provide a rational basis for their clinical management. More generally, the powerful interaction between the STN and 5-HT system uncovered here offers insights into the high level of comorbidity of basal ganglia disease and mood disorder.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17942692      PMCID: PMC2040465          DOI: 10.1073/pnas.0704144104

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  60 in total

Review 1.  Neurobiology of suicidal behaviour.

Authors:  J John Mann
Journal:  Nat Rev Neurosci       Date:  2003-10       Impact factor: 34.870

2.  Silent plateau potentials, rhythmic bursts, and pacemaker firing: three patterns of activity that coexist in quadristable subthalamic neurons.

Authors:  Jason I Kass; Isabelle M Mintz
Journal:  Proc Natl Acad Sci U S A       Date:  2005-12-22       Impact factor: 11.205

Review 3.  Deep brain stimulation for neurologic and neuropsychiatric disorders.

Authors:  Thomas Wichmann; Mahlon R Delong
Journal:  Neuron       Date:  2006-10-05       Impact factor: 17.173

4.  Acute and separate modulation of motor and cognitive performance in parkinsonian rats by bilateral stimulation of the subthalamic nucleus.

Authors:  Yasin Temel; Veerle Visser-Vandewalle; Brenda Aendekerk; Bart Rutten; Sonny Tan; Bart Scholtissen; Christoph Schmitz; Arjan Blokland; Harry W M Steinbusch
Journal:  Exp Neurol       Date:  2005-05       Impact factor: 5.330

5.  High-frequency stimulation of the subthalamic nucleus silences subthalamic neurons: a possible cellular mechanism in Parkinson's disease.

Authors:  C Magariños-Ascone; J H Pazo; O Macadar; W Buño
Journal:  Neuroscience       Date:  2002       Impact factor: 3.590

6.  Evidence that central 5-HT2A and 5-HT2B/C receptors regulate 5-HT cell firing in the dorsal raphe nucleus of the anaesthetised rat.

Authors:  L J Boothman; K A Allers; K Rasmussen; T Sharp
Journal:  Br J Pharmacol       Date:  2003-07       Impact factor: 8.739

7.  Ten-Hertz stimulation of subthalamic nucleus deteriorates motor symptoms in Parkinson's disease.

Authors:  Lars Timmermann; Lars Wojtecki; Joachim Gross; Ralph Lehrke; Jürgen Voges; Mohammed Maarouf; Harald Treuer; Volker Sturm; Alfons Schnitzler
Journal:  Mov Disord       Date:  2004-11       Impact factor: 10.338

Review 8.  Deep brain stimulation for Parkinson's disease: disrupting the disruption.

Authors:  Andres M Lozano; Jonathan Dostrovsky; Robert Chen; Peter Ashby
Journal:  Lancet Neurol       Date:  2002-08       Impact factor: 44.182

9.  The Effects of Activation or Inhibition of the Subthalamic Nucleus on the Metabolic and Electrophysiological Activities Within the Pallidal Complex and Substantia Nigra in the Rat.

Authors:  Jean Féger; Patricia Robledo
Journal:  Eur J Neurosci       Date:  1991       Impact factor: 3.386

10.  Bilateral high-frequency stimulation of the subthalamic nucleus on attentional performance: transient deleterious effects and enhanced motivation in both intact and parkinsonian rats.

Authors:  Christelle Baunez; Anastasia Christakou; Yogita Chudasama; Claude Forni; Trevor W Robbins
Journal:  Eur J Neurosci       Date:  2007-02       Impact factor: 3.386

View more
  41 in total

Review 1.  Preclinical studies modeling deep brain stimulation for depression.

Authors:  Clement Hamani; José N Nobrega
Journal:  Biol Psychiatry       Date:  2012-06-29       Impact factor: 13.382

Review 2.  [Deep brain stimulation for neurological and psychiatric diseases: animal experiments on effect and mechanisms].

Authors:  C Winter; D Harnack; A Kupsch
Journal:  Nervenarzt       Date:  2010-06       Impact factor: 1.214

Review 3.  Selective GABA release as a mechanistic basis of high-frequency stimulation used for the treatment of neuropsychiatric diseases.

Authors:  Thomas J Feuerstein; Miriam Kammerer; Carl Hermann Lücking; Andreas Moser
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2011-05-02       Impact factor: 3.000

4.  Animal models of depression: molecular perspectives.

Authors:  Vaishnav Krishnan; Eric J Nestler
Journal:  Curr Top Behav Neurosci       Date:  2011

Review 5.  Effects of Subthalamic Nucleus Deep Brain Stimulation on Facial Emotion Recognition in Parkinson's Disease: A Critical Literature Review.

Authors:  S Kalampokini; E Lyros; P Lochner; K Fassbender; M M Unger
Journal:  Behav Neurol       Date:  2020-07-17       Impact factor: 3.342

Review 6.  Multisite intracerebral microdialysis to study the mechanism of L-DOPA induced dopamine and serotonin release in the parkinsonian brain.

Authors:  S Navailles; M Lagière; A Contini; P De Deurwaerdère
Journal:  ACS Chem Neurosci       Date:  2013-04-15       Impact factor: 4.418

Review 7.  Multiple controls exerted by 5-HT2C receptors upon basal ganglia function: from physiology to pathophysiology.

Authors:  P De Deurwaerdère; M Lagière; M Bosc; S Navailles
Journal:  Exp Brain Res       Date:  2013-04-25       Impact factor: 1.972

8.  STN vs. GPi Deep Brain Stimulation: Translating the Rematch into Clinical Practice.

Authors:  Nolan R Williams; Kelly D Foote; Michael S Okun
Journal:  Mov Disord Clin Pract       Date:  2014-04-01

9.  The sigma-1 antagonist BMY-14802 inhibits L-DOPA-induced abnormal involuntary movements by a WAY-100635-sensitive mechanism.

Authors:  Melanie A Paquette; Katherine Foley; Elizabeth G Brudney; Charles K Meshul; Steven W Johnson; S Paul Berger
Journal:  Psychopharmacology (Berl)       Date:  2009-03-13       Impact factor: 4.530

10.  Adenoviral vectors for highly selective gene expression in central serotonergic neurons reveal quantal characteristics of serotonin release in the rat brain.

Authors:  Kheira Benzekhroufa; Beihui Liu; Feige Tang; Anja G Teschemacher; Sergey Kasparov
Journal:  BMC Biotechnol       Date:  2009-03-19       Impact factor: 2.563

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.